Buchumschlag

Relapse and survival after relapse among children with cancer in Denmark: 2001–2021

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mie Mølgaard Andersen, Marie Christine Lundius Sørensen, Kjeld Schmiegelow, Astrid Marie Sehested, Klaus Rostgaard, Marianne Olsen, Torben Stamm Mikkelsen, Peder Skov Wehner, Lisa Lyngsie Hjalgrim, Signe Holst Søegaard
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Pediatric Blood & Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Radiotherapy Delivery in Deep Inspiration for Pediatric Patients—Final Results of the Phase II Feasibility Study TEDDI
von: Daniella Elisabet Østergaard, et al.
Veröffentlicht: (2026)

Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study
von: Mette Tiedemann Skipper, et al.
Veröffentlicht: (2025)

Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark
von: Mia Giertz, et al.
Veröffentlicht: (2024)

Feasibility of an Intravenous Home Chemotherapy Intervention With Low‐Dose Cytarabine Administered by Parents (INTACTatHome)
von: Louise Ingerslev Roug, et al.
Veröffentlicht: (2025)

Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training
von: Lise Marie Krogh, et al.
Veröffentlicht: (2024)

Lung relapse pattern in children with metastatic Wilms tumor
von: Giulia Fichera, et al.
Veröffentlicht: (2024)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
von: Laura Almási, et al.
Veröffentlicht: (2026)

Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse
von: Swetha Palla, et al.
Veröffentlicht: (2025)

Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
von: Wenqian Wang, et al.
Veröffentlicht: (2026)

Alpha‐emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor
von: Andrew Wahba, et al.
Veröffentlicht: (2024)

Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
von: Stephanie Fetzko, et al.
Veröffentlicht: (2024)

Outcomes of relapsed favorable‐histology Wilms tumor in non‐clinical trial setting
von: Netta Schneller, et al.
Veröffentlicht: (2024)

Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020
von: Mona P. Ankerstjerne, et al.
Veröffentlicht: (2024)

Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”
Veröffentlicht: (2025)

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
von: Molly Mack, et al.
Veröffentlicht: (2026)

Correction to “Outcomes of Relapsed Favorable‐Histology Wilms Tumor in Non‐Clinical Trial Setting”
Veröffentlicht: (2025)

Retrospective Review of Spinal Cord Compression Occurrences and Management in Children With Relapsed, Progressing, or Refractory Malignancies
von: Adi Nitzan‐Luques, et al.
Veröffentlicht: (2024)

Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis
von: Andrea Ferrari, et al.
Veröffentlicht: (2024)

Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide
von: Caroline Donzé, et al.
Veröffentlicht: (2024)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
von: Andrew E. Place, et al.
Veröffentlicht: (2025)

Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
von: Shubham Sahni, et al.
Veröffentlicht: (2026)

Treatment of pediatric refractory or relapsed Epstein–Barr virus‐associated hemophagocytic syndrome with PD‐1 inhibitors
von: Shu‐Yi Guo, et al.
Veröffentlicht: (2024)

Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
von: Kathryn S. Sutton, et al.
Veröffentlicht: (2025)

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort
von: Maria Debora De Pasquale, et al.
Veröffentlicht: (2026)

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
von: Daniel A. Morgenstern, et al.
Veröffentlicht: (2026)

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre‐ and Post‐Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure
von: Andrew Muskara, et al.
Veröffentlicht: (2025)

Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor
von: Caroline Donze, et al.
Veröffentlicht: (2025)

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
von: Seth E. Karol, et al.
Veröffentlicht: (2025)

Focal Nodular Hyperplasia (FNH)/FNH‐Like Lesions: An Important Potential Mimic of Relapsed Malignancy in Pediatric Cancer Patients
von: Jonathan Abrams, et al.
Veröffentlicht: (2025)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
von: Thomas J. Jackson, et al.
Veröffentlicht: (2026)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
von: Marko Kavcic, et al.
Veröffentlicht: (2025)

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
von: Vicente Santa‐Maria Lopez, et al.
Veröffentlicht: (2026)

A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)
von: Euan Ballantyne, et al.
Veröffentlicht: (2024)

Homoharringtonine in Relapsed/Refractory Paediatric T‐Cell Acute Lymphoblastic Leukaemia—A Case Series and a Report on the Use of In Vitro Drug Profiling
von: Pui Yung Grace Tong, et al.
Veröffentlicht: (2025)

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose
von: Jonathan D. Bender, et al.
Veröffentlicht: (2026)

Blastic Plasmacytoid Dendritic Cell Neoplasm With Sinonasal and Testicular Sanctuary Site Relapses: Local Radiotherapy as a Bridge to Second Allogeneic Transplantation
von: Fei Luo, et al.
Veröffentlicht: (2026)

Clinical Relapse Versus Treatment Failure: The Case for Surveillance for Re‐Appearance of Minimal Measurable Disease in Pediatric Patients with Higher Risk B‐ALL
von: Paul S. Gaynon, et al.
Veröffentlicht: (2024)

Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
von: Jonathan Metts, et al.
Veröffentlicht: (2024)

Isolated central nervous system relapse in two adolescents with primary mediastinal large B‐cell lymphoma after treatment with R‐DA‐EPOCH
von: Cricket Gullickson, et al.
Veröffentlicht: (2024)

Pediatric Hematology/Oncology Fellowship Match Trends in the United States: Analysis From 2008 to 2025
von: Saman K. Hashmi, et al.
Veröffentlicht: (2025)